Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 2157Session 2025-2026

Expanding pharmacist's scope of practice to include point-of-care testing for and treatment of COVID-19.

As Introduced

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content Kansas Legislature kslegislature.gov menu Home House account_balanceAbout the House groupsRepresentatives campaignEvents chairSeating Chart auto_storiesJournals & Calendars manage_accountsChief Clerk of the House gavelRules Senate account_balanceAbout the Senate groupsSenators campaignEvents assignment_indAppointments chairSeating Chart auto_storiesJournals & Calendars manage_accountsSecretary of the Senate gavelRules Committees groupsCommittees eventHearing Schedule handshakeConference Committee Schedule Measures & Laws gavelAll Measures account_balanceHouse Measures account_balanceSenate Measures account_balanceVotes topicSubject Index summarizeReports menu_bookStatutes schoolHow a Bill Becomes Law menu_bookLegislative Procedure Manual Today campaignLive Floor Activity videocamHouse Video videocamSenate Video live_tvStatehouse Live & Archive smart_displayYouTube Channel Resources Archive Search description Go to bill or resolution arrow_forward A− A+ search Search bills, resolutions, and statutes help

Keywords
Enter any words to search bills, statutes, and documents.
water quality funding

Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611

Statute Number
68-102 72-3715

Exact Phrase
Wrap your query in quotes.
“rules of evidence”

Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget

    Searching…

    No results found.

    search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search
    1. HB 2157›
    2. HB 2157 — As Introduced

    Kansas Legislature

    HB 2157 — As Introduced

    picture_as_pdf Download PDF Session of 2025HOUSE BILL No. 2157By Committee on Health and Human ServicesRequested by Heather Sprague on behalf of the Kansas Association of Chain Drugstores1-291AN ACT concerning pharmacists and pharmacy; relating to the state board 2of pharmacy; expanding the pharmacist's scope of practice to include 3point-of-care testing for and treatment of COVID-19; amending K.S.A. 42024 Supp. 65-16,131 and repealing the existing section.56Be it enacted by the Legislature of the State of Kansas:7Section 1. K.S.A. 2024 Supp. 65-16,131 is hereby amended to read as 8follows: 65-16,131. (a) A pharmacist may initiate therapy within the 9framework of a statewide protocol for the following health conditions:10(1) Influenza;11(2) streptococcal pharyngitis; or12(3) urinary tract infection; or13(4) COVID-19.14(b) The collaborative drug therapy management advisory committee 15established pursuant to K.S.A. 65-1677, and amendments thereto, may 16adopt a statewide protocol for each condition listed in subsection (a). In 17establishing such statewide protocols, the committee shall specify:18(1) The medications or categories of medications included in the 19protocol for each health condition;20(2) the training or qualifications required for pharmacists to 21implement the protocols;22(3) requirements for documentation and maintenance of records, 23including patient inclusion and exclusion criteria, medical referral criteria, 24patient assessment tools based on current clinical guidelines, follow-up 25monitoring or care plans and the pharmacist's adherence to the applicable 26protocols; and27(4) communication requirements, including, but not limited to, 28notification to the patient's personal or primary care provider.29(c) The board may deny an application or renewal or revoke or 30suspend the license of a pharmacist upon a finding that the pharmacist has 31violated the provisions of this section or failed to practice within the 32framework of statewide protocols established pursuant to this section by 33the collaborative drug therapy management advisory committee.34(d) This section shall take effect and be in force on and after July 1, 12022.2Sec. 2. K.S.A. 2024 Supp. 65-16,131 is hereby repealed.3Sec. 3. This act shall take effect and be in force from and after its 4publication in the statute book. search keyboard_arrow_up keyboard_arrow_down Page 1 Page 2 arrow_upward Top Kansas State Legislature

    300 SW 10th Ave, Topeka, KS 66612

    Ad Astra Per Aspera

    Kansas Legislative Hotline
    In-State: 1-800-432-3924
    Out-of-State: 785-296-2149

    Government

    • Legislators
    • House
    • Representatives
    • Senate
    • Senators
    • Committees

    Resources

    • Bills & Measures
    • Today
    • Live
    • Journals
    • Calendars
    • Archived Records
    • Laws
    • Search
    • RSS Feeds

    Support

    • Contact Us
    • Accessibility
    • Privacy Policy
    • Visit Us
    © 2026 Kansas State Legislature. All rights reserved. Data updated 0 minutes ago · 3:42 PM 11/14/2026

    Official text from the Kansas Legislature. Formatting has been adapted for reading on Ratifi.